Cargando…
Unlocking the potential of targeting histone-modifying enzymes for treating IBD and CRC
Dysregulation of histone modifications has been implicated in the pathogenesis of both inflammatory bowel disease (IBD) and colorectal cancer (CRC). These diseases are characterized by chronic inflammation, and alterations in histone modifications have been linked to their development and progressio...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496233/ https://www.ncbi.nlm.nih.gov/pubmed/37697409 http://dx.doi.org/10.1186/s13148-023-01562-1 |